These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Toward an effective targeted chemotherapy for multiple myeloma. Polson AG; Sliwkowski MX Clin Cancer Res; 2009 Jun; 15(12):3906-7. PubMed ID: 19509145 [TBL] [Abstract][Full Text] [Related]
44. Organ preservation ... where do we stand? Lefebvre JL Acta Otorhinolaryngol Belg; 1999; 53(3):223-5. PubMed ID: 10635397 [TBL] [Abstract][Full Text] [Related]
45. Antibodies and hematologic malignancies. Smith MR Cancer J; 2008; 14(3):184-90. PubMed ID: 18536558 [TBL] [Abstract][Full Text] [Related]
46. Development trends for monoclonal antibody cancer therapeutics. Reichert JM; Valge-Archer VE Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406 [TBL] [Abstract][Full Text] [Related]
47. [Progress in targeting therapy for hepatic cancer]. Uchino J; Une Y; Kamiya T; Kawata A Gan To Kagaku Ryoho; 1994 May; 21(6):765-71. PubMed ID: 8185333 [TBL] [Abstract][Full Text] [Related]
48. [Laser therapy of pharyngeal and hypopharyngeal cancer]. Rudert H HNO; 1994 Mar; 42(3):141-2. PubMed ID: 8175377 [No Abstract] [Full Text] [Related]
49. The psychodynamics of prolonged treatment in a patient with cancer of the hypopharynx. Feldman JE; Baker KH Cancer Nurs; 1988 Dec; 11(6):362-7. PubMed ID: 3233588 [No Abstract] [Full Text] [Related]
52. [Consideration on the treatment of hypopharyngeal cancer from the view of NCCN Guideline 2014]. Wen S; Wang B Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):637-9. PubMed ID: 26714608 [No Abstract] [Full Text] [Related]
53. [Present status of throat-cancer therapy]. Krajina Z Lijec Vjesn; 1978 Jul; 100(7):456-7. PubMed ID: 703514 [No Abstract] [Full Text] [Related]
54. [Combination therapy of oropharyngeal and hypopharyngeal cancer: present status and outlook]. Sauer R; Schwab W Sonderb Strahlenther Onkol; 1987; 81():166-70. PubMed ID: 3824127 [No Abstract] [Full Text] [Related]
55. [Radio-hyperthermia in oro- and hypopharyngeal cancer]. Herbst M Sonderb Strahlenther Onkol; 1987; 81():114-21. PubMed ID: 3824123 [No Abstract] [Full Text] [Related]
56. Options for preserving the larynx in patients with advanced laryngeal and hypopharyngeal cancer. Wolf GT Ear Nose Throat J; 2001 Dec; 80(12):897-901. PubMed ID: 11775526 [TBL] [Abstract][Full Text] [Related]